JPRN-jRCT2080222546未知2 期
Phase 2 study to evaluate efficacy and safety of DS-8500a in patients with Type 2 Diabetes Mellitus
DAIICHISANKYO Co.,Ltd.0 个研究点目标入组 90 人开始时间: 2014年6月30日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 69age old（—）
- 性别
- All
入选标准
- •Main Inclusion Criteria;
- •Type 2 Diabetes Mellitus
排除标准
- •Main Exclusion Criteria;
- •Type 1 Diabetes Mellitus
- •Patients under insulin treatment
- •Patients with hepatic disorder
- •Patients with renal disorder
研究者
相似试验
尚未招募
2 期
Effect of ayurvedic medicine drvyadi rasakriya in diabetesCTRI/2023/01/049263Aushadhi Bhavan
已完成
2 期
Phase II study assessing the efficacy and safety of lenvatinib for anaplastic thyroid cancer (HOPE)JPRN-UMIN000020773Translational Research Informatics Center, Foundation for Biomedical Research and Innovation39
已完成
不适用
Phase II study evaluating efficacy and safety of peripheral blood stem cell harvest with bortezomib for multiple myelomaMultiple MyelomaJPRN-UMIN000010258Fourth Department of Internal Medicine, Sapporo Medical University, School of Medicine30
招募中
2 期
uPBSCT with PTCY for ATadult T-cell leukemia/lymphomaJPRN-jRCTs031200375Fukuda Takahiro24
招募中
不适用
Phase II study to evaluate efficacy and safety of retherapy with bendamustine and rituximab regimens in patients with relapsed/refractory indolent B-cell lymphomas and mantle cell lymphomasJPRN-UMIN000011152B-SRIM Study Group38